Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
EU Authorization Before US? Biologics Manufacturing Is Likely To Blame
May 26 2025
•
By
Bridget Silverman
Most new products are approved in the US before the European Union, but those authorized in Europe first mostly are biologics.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Regional Comparisons
More from Complete Response Letters